GSK & Sanofi join forces to discover an effective vaccine for COVID-19
Category: #health  By Nikita Chaurasia  Date: 2020-04-15
  • share
  • Twitter
  • Facebook
  • LinkedIn

GSK & Sanofi join forces to discover an effective vaccine for COVID-19

Amidst growing concerns over the coronavirus, numerous medical institutes and pharmaceutical companies are diligently working on developing an effective vaccine to tackle this deadly virus. France’s Sanofi S.A. and Britain’s GlaxoSmithKline plc (GSK) are a shining example of this statement as two of the world’s largest vaccine creators join forces to develop and mass produce a vaccine for COVID-19.

Reportedly, the pharma giants are planning to commence vaccine trials by the second half of 2020 and, if everything goes as per the plan, will make them widely accessible by Q2 of 2021.

According to Paul Hudson, Chief Executive Officer, Sanofi, during these unprecedented times where the whole world is going through a health crisis, a single company wouldn’t be able to tackle this issue. As a result, Sanofi believes it is beneficial for it to share its resources and expertise with its partners and allies like GSK. The main focus of this partnership is to create and provide ample quantities of drugs that would help cure this disease.

Currently, the market is crowded with dozens of teams ranging from universities to firms such as Moderna, Inovio and Johnson & Johnson who are constantly working on drug development and clinical trials. Most of them are on the verge of developing a sure shot vaccine for COVID-19, with almost 78 candidates being actively tested.

However, Sanofi and GSK believe that their size would give them a decisive edge over competitors, as the infected patients figure scales up to almost 2 million worldwide.

Speaking on the development, David Loew, Executive Vice President of Vaccine Branch, Sanofi Pasteur, said that the real challenge is to not just discover a suitable vaccine candidate but also to produce it at a massive scale, scaling up to hundreds of millions of doses.

Source Credit: https://www.euronews.com/2020/04/14/coronavirus-vaccine-pharma-giants-gsk-and-sanofi-team-up-to-find-covid-19-solution

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia    

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More

More News By Nikita Chaurasia

Emirates could slash 30,000 jobs to lower cost during COVID-19 crisis
Emirates could slash 30,000 jobs to lower cost during COVID-19 crisis
By Nikita Chaurasia

Emirates Group has reportedly been planning to lay off around 30,000 jobs in order to lower the cost amid the pandemic outbreak, that will soon bring the total number of employees working by nearly 30% from over 105,000 close to March-end. Apparentl...

Apple acquires live event recording and VR broadcaster NextVR
Apple acquires live event recording and VR broadcaster NextVR
By Nikita Chaurasia

Apple has recently confirmed that it has acquired NextVR, which is a virtual reality startup that specializes in recording live events such as sports matches and concerts for  VR experience. The announcement made by the company came after the pu...

Grant worth $6mn introduced in Singapore to support FinTech companies
Grant worth $6mn introduced in Singapore to support FinTech companies
By Nikita Chaurasia

The recent coronavirus pandemic has largely affected umpteen businesses globally. In a bid to help Fintech companies meet their day-to-day expenses, the Monetary Authority of Singapore (MAS), has established the FinTech Solidarity Grant that would pr...